Evidence 1
Activity
Activity
Blood-Brain Barrier
Target
hCMEC/D3 and NHA cells
Assay & Model
TEM imaging
Responsive to thrombin cleavage, reduced the cytotoxicity of Tat-NR2B9c, and increased BBB permeabil
Origin/Source
Dynamic light scattering
Better circulation time, better targeting ability and penetrating efficiency to the injured brain, a
Traumatic brain injury
Source & Reference
NA
B3Pdb
Other
Chemically synthesized
Intravenous
Treatment reduced the injury size
Combined with Tat-NR2B9c